文献速递前列腺癌

治疗机构收治量与晚期前列腺癌患者生存的关系

Treatment Facility Volume and Survival in Patients with Advanced Prostate Cancer.
PubMed 文献 · Eur Urol Oncol · 2019-07-18

该研究利用美国国家癌症数据库2004至2013年数据,纳入64815例晚期前列腺癌患者,按机构年治疗量四分位分组,评估机构收治量与总生存的关系。结果显示,最高四分位机构较最低四分位机构死亡风险降低(HR 0.82,95%CI 0.77-0.88,p<0.001),且在不同患者队列中结果一致。

要点

  • 机构年治疗量最高四分位与最低四分位相比,晚期前列腺癌患者总生存改善(HR 0.82)。
  • 限制性立方样条模型显示,随着机构治疗量增加,死亡风险持续下降。
  • 该生存优势在按疾病特征和治疗特征缩窄队列后仍持续存在,效应量级相似。

核心结论

  • 在近65000例晚期前列腺癌患者的回顾性分析中,较高的机构治疗量与总生存改善相关。
  • 按疾病和治疗特征缩窄队列后,该总生存优势仍持续存在,效应量级相似。

研究设计与样本

  • 回顾性分析,查询美国国家癌症数据库(NCDB)2004至2013年数据,纳入64815例晚期前列腺癌患者(定义为T4、N+或M+疾病)。
  • 评估6个预定义患者队列:队列A包括所有晚期前列腺癌患者;B队列仅包括M0患者;C队列仅包括M1患者。
  • 机构按年治疗量中位数分为四分位。

主要发现

  • 总生存随机构治疗量增加而改善:最高四分位 vs 最低四分位,风险比(HR)0.82,95%置信区间(CI)0.77-0.88,p<0.001。
  • 该结果在不同患者队列中一致。
  • 采用自然立方样条的Cox回归模型显示,随着治疗量增加,死亡风险持续下降。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 局限性包括回顾性分析。
  • 缺乏精确的治疗信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Despite improvements in medical management of advanced prostate cancer (aPC), it continues to be a leading cause of cancer death in men. Contemporary management of men with aPC is complex and requires resources to be more readily available at high-volume facilities. OBJECTIVE: To determine the relationship between facility volume and survival in men with aPC. DESIGN, SETTING, AND PARTICIPANTS: The National Cancer Database (NCDB) was queried from 2004 to 2013 for aPC, defined as T4, N+, or M+ disease, identifying 64815 patients. Six predefined patient cohorts were evaluated. Cohort "A" included all patients with aPC. "B" cohorts included only M0 patients. "C" cohorts included only M1 patients. Facilities were divided into quartiles based on median treatment volume (patients/yr). INTERVENTION: Diagnosis and management of aPC at an NCDB-reporting facility. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Overall survival (OS) was assessed as a function of facility volume. Multivariable Cox regression models were fitted. Cox regressions using natural cubic splines were used to test for nonlinear relationships between volume and OS. RESULTS AND LIMITATIONS: OS improved as facility volume increased (top quartile vs bottom quartile, hazard ratio 0.82, 95% confidence interval 0.77-0.88, p<0.001) and was consistent across patient cohorts. Spline models demonstrate a continuous decrease in hazard of death as volume increases. Limitations include the retrospective analysis and a lack of precise treatment information. CONCLUSIONS: In this retrospective analysis of nearly 65000 men who presented with aPC, we demonstrate an association between higher facility volume and improvements in OS. This OS advantage persisted with similar magnitudes of effect after narrowing the cohorts by disease and treatment characteristics. PATIENT SUMMARY: In this retrospective review of the National Cancer Database, we analyzed the association between treatment facility volume and survival in men who are diagnosed with advanced prostate cancer. We found that survival improved as volume increased, indicating a possible imbalance of resources and expertise that favors higher-volume facilities.

来源:Eur Urol Oncol,查看原文。版权归原作者所有。

引用

  1. Joshi SS, Handorf ER, Sienko D, et al. Treatment Facility Volume and Survival in Patients with Advanced Prostate Cancer. Eur Urol Oncol. 2019. PMID: 31326500. doi:10.1016/j.euo.2019.06.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。